Charles River Laboratories (CRL) returns
Charles River Laboratories returns over 10 years
$1,000 invested in Charles River Laboratories ten years ago was worth $4,729 at the close on October 30, 2026, with dividends reinvested: an average return of 16.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +21.8% | — | $1,218 | -0.9% |
| 3 months | +53.2% | — | $1,532 | +2.1% |
| Year to date | +80.2% | — | $1,802 | +11.7% |
| 1 year | +100.7% | — | $2,007 | +12.4% |
| 3 years | +118.5% | +29.8% | $2,185 | +88.5% |
| 5 years | -19.9% | -4.3% | $801.04 | +76.0% |
| 10 years | +372.9% | +16.8% | $4,729 | +316.6% |
Charles River Laboratories return by calendar year
| Year | CRL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +80.2% | +11.7% | +68.5% |
| 2025 | +8.1% | +17.7% | -9.7% |
| 2024 | -21.9% | +24.9% | -46.8% |
| 2023 | +8.5% | +26.2% | -17.7% |
| 2022 | -42.2% | -18.2% | -24.0% |
| 2021 | +50.8% | +28.7% | +22.1% |
| 2020 | +63.6% | +18.4% | +45.2% |
| 2019 | +35.0% | +31.2% | +3.7% |
| 2018 | +3.4% | -4.6% | +8.0% |
| 2017 | +43.7% | +21.7% | +22.0% |
| 2016 | -5.2% | +12.0% | -17.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: CRL financials · CRL valuation
No forecast, no recommendation. This page describes Charles River Laboratories from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.